More on SKYE

- Summary
- Chart
- Profile
- Historical

Data

- Earnings (+43.2% Growth)
- Ratings (7.1 Score)

Upcoming Events

- Earnings (8/7/26)

News

- Analyst Ratings
- Earnings Related
- Guidance
- Insider Trades
- Mgmt Changes
- M & A
- Retail Sales
- Rumors
- Stock Buybacks
More...

Skye Bioscience (NQ:SKYE)
Delayed: 0.65 +0.02 (3.17%)
Prev. Close $0.63  
Open$0.63 
52 Wk High$ 
52 Wk Low$ 
Day High$0.66 
Day Low$0.62 
P/E N/A  
EPS$ 
Volume97,306 

Friends, Peers and Foes (?): SKYED, CNTX HALO (more...)

Jun 23, 2026 06:02 AM Form 8-K Skye Bioscience, Inc. For: Jun 18
May 29, 2026 04:55 PM Form 8-K Skye Bioscience, Inc. For: May 26
May 20, 2026 07:02 AM Skye Bioscience clears nimacimab dose escalation in obesity trial
May 20, 2026 07:00 AM Skye Announces Cohort Review Committee Approved Opening of Cohort 2 Based on Favorable Safety Data from First Four Participants Treated in Cohort 1
May 15, 2026 04:01 PM Form 8-K Skye Bioscience, Inc. For: May 13
May 12, 2026 01:33 PM UPDATE – Skye Bioscience Reports First Quarter 2026 Financial Results and Business Update
May 12, 2026 07:59 AM Skye Bioscience (SKYE) PT Lowered to $6 at Piper Sandler
May 11, 2026 04:22 PM Skye Bioscience (SKYE) Misses Q1 EPS by 32c
May 11, 2026 04:22 PM Skye Bioscience (SKYE) Misses Q1 EPS by 32c
May 11, 2026 04:01 PM Form 10-Q Skye Bioscience, Inc. For: Mar 31
View All Articles

Entities mentioned with SKYE

View All Entities